IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.379
+0.011 (2.99%)
At close: Dec 20, 2024, 4:00 PM
0.365
-0.014 (-3.75%)
After-hours: Dec 20, 2024, 7:54 PM EST
IGC Pharma Employees
IGC Pharma had 67 employees as of March 31, 2024. The number of employees increased by 6 or 9.84% compared to the previous year.
Employees
67
Change (1Y)
6
Growth (1Y)
9.84%
Revenue / Employee
$17,657
Profits / Employee
-$187,597
Market Cap
29.35M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Accelerate Diagnostics | 134 |
| RAPT Therapeutics | 131 |
| IRIDEX | 111 |
| KALA BIO | 43 |
| Calidi Biotherapeutics | 41 |
| OneMedNet | 20 |
| ProMIS Neurosciences | 7 |
| Anebulo Pharmaceuticals | 3 |
IGC News
- 2 days ago - IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025 - Accesswire
- 19 days ago - IGC Pharma Advances IGC-AD1 as a Potential Alzheimer's Therapy Addressing Cognitive Impairment and Underlying Disease Pathology - Accesswire
- 26 days ago - IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment - Business Wire
- 5 weeks ago - IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer's Pipeline - Accesswire
- 6 weeks ago - IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer's and Weight Loss Therapies - Accesswire
- 2 months ago - IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1 - Accesswire
- 2 months ago - IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge - Accesswire
- 3 months ago - IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment - Business Wire